Xenopat: Your Tumor in a Mouse
Labcritics visited Xenopat, an innovative company dedicated to the orthotopic implantation of human tumors in mice. This technology allows Xenopat to offer services to companies developing new anticancer drugs and personalized cancer treatments. We had the pleasure of speaking with Dr. Anna Portela, CEO and co-founder, and Dr. Alberto Villanueva, CSO and co-founder.
For more information, visit xenopat.com.
Labcritics Alerts / Sign-up to get alerts on discounts, new products, apps, protocols and breakthroughs in tools that help researchers succeed.
